Bajaj Healthcare gets Gujarat FDA nod to manufacture hydhroxychloroquine sulphate
Posted by
www.biotecnika.org
The company will commence production of hydhroxychloroquine sulphate
API in the next 3 weeks at its Vadodara facility and it is estimated
to produce 15 Mts of API per month, Bajaj Healthcare said. It has
started the production of hydroxychloroquine FDF (tablets) at Vadodara
unit and is expected to produce around 1.5 crore hydroxychloroquine
sulphate tablets.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bajaj-healthcare-gets-gujarat-fda-nod-to-manufacture-hydhroxychloroquine-sulphate/articleshow/75201781.cms
Subscribe to:
Post Comments (Atom)
Post a Comment